Allo-HSCT for acute leukemia of ambiguous lineage in adults: The comparison between standard conditioning and intensified conditioning regimens

Annals of Hematology

Volumn 92, Issue 5, 2013, Pages 679-687

  Liu, Qi Fa ^a   Fan, Zhi Ping ^a   Wu, Mei Qing ^a   Sun, Jing ^a   Wu, Xiu Li ^a,b   Xu, Dan ^a   Jiang, Qian Li ^a   Zhang, Yu ^a   Huang, Fen ^a   Wei, Yong Qiang ^a   Zhao, Jie ^a   Yu, Guo Pan ^a   Meng, Fan Yi ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

^b MEDICAL COLLEGE OF JINAN UNIVERSITY   (China)

Author keywords

Acute leukemia of ambiguous lineage; Allo HSCT; Conditioning regimens

Indexed keywords

ASPARAGINASE; BUSULFAN; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; CYTARABINE; DAUNORUBICIN; ETOPOSIDE; FLUDARABINE; HOMOHARRINGTONINE; IDARUBICIN; METHOTREXATE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID; PREDNISONE; THYMOCYTE ANTIBODY; VINCRISTINE;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; AGE; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; CAUSE OF DEATH; CHILD; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DONOR LYMPHOCYTE INFUSION; FEMALE; GRAFT VERSUS HOST REACTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INTERMETHOD COMPARISON; LEUKEMIA RELAPSE; MAJOR CLINICAL STUDY; MALE; MORTALITY; OVERALL SURVIVAL; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCHOOL CHILD; WHOLE BODY RADIATION;

ADOLESCENT; ADULT; BUSULFAN; CHILD; CYCLOPHOSPHAMIDE; CYTARABINE; ETOPOSIDE; FEMALE; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LEUKEMIA, BIPHENOTYPIC, ACUTE; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; STANDARD OF CARE; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, HOMOLOGOUS; WHOLE-BODY IRRADIATION; YOUNG ADULT;

EID: 84877921865     PISSN: 09395555     EISSN: 14320584     Source Type: Journal    
DOI: 10.1007/s00277-012-1662-4     Document Type: Article

References (34)

1. Gerr H, Zimmermann M, Schrappe M et al (2010) Acute leukaemias of ambiguous lineage in children: characterization, prognosis and therapy recommendations. Br J Haematol 149(1):84-92
2. Owaidah TM, Al BA, Iqbal MA et al (2006) Cytogenetics, molecular and ultrastructural characteristics of biphenotypic acute leukemia identified by the EGIL scoring system. Leukemia 20(4):620-626
3. Rubnitz JE, Onciu M, Pounds S et al (2009) Acute mixed lineage leukemia in children: the experience of St Jude Children's Research Hospital. Blood 113(21):5083-5089
4. Thalhammer-Scherrer R, Mitterbauer G, Simonitsch I et al (2002) The immunophenotype of 325 adult acute leukemias: relationship to morphologic and molecular classification and proposal for a minimal screening program highly predictive for lineage discrimination. Am J Clin Patho 117(3):380-389
5. Xu XQ, Wang JM, Lu SQ et al (2009) Clinical and biological characteristics of adult biphenotypic acute leukemia in comparison with that of acute myeloid leukemia and acute lymphoblastic leukemia: a case series of a Chinese population. Haematologica 94(7):919-927
6. Jaffe ES (2009) The 2008 WHO classification of lymphomas: implications for clinical practice and translational research. Hematology Am Soc Hematol Educ Program 523-531.
7. Sabattini E, Bacci F, Sagramoso C et al (2010) WHO classification of tumours of haematopoietic and lymphoid tissues in 2008: an overview. Pathologica 102(3):83-87
8. Al-Seraihy AS, Owaidah TM, Ayas M et al (2009) Clinical characteristics and outcome of children with biphenotypic acute leukemia. Haematologica 94(12):1682-1690
9. Aribi A, Bueso-Ramos C, Estey E et al (2007) Biphenotypic acute leukaemia: a case series. Br J Haematol 138(2):213-216
10. Killick S, Matutes E, Powles RL et al (1999) Outcome of biphenotypic acute leukemia. Haematologica 84(8):699-706
11. Park JA, Ghim TT, Bae K et al (2009) Stem cell transplant in the treatment of childhood biphenotypic acute leukemia. Pediatr Blood Cancer 53(3):444-452
12. Rubio MT, Dhedin N, Boucheix C et al (2003) Adult T-biphenotypic acute leukaemia: clinical and biological features and outcome. Br J Haematol 123(5):842-849
13. Zheng C, Wu J, Liu X et al (2009) What is the optimal treatment for biphenotypic acute leukemia? Haematologica 94(12):1778-1780
14. Johny A, Song KW, Nantel SH et al (2006) Early stem cell transplantation for refractory acute leukemia after salvage therapy with high-dose etoposide and cyclophosphamide. Biol Blood Marrow Transplant 12(4):480-489
15. Matutes E, Morilla R, Farahat N et al (1997) Definition of acute biphenotypic leukemia. Haematologica 82(1):64-66
16. Liu QF, Fan ZP, Zhang Y et al (2009) Sequential intensified conditioning and tapering of prophylactic immunosuppressants for graft-versus-host disease in allogeneic hematopoietic stem cell transplantation for refractory leukemia. Biol Blood Marrow Transplant 15(11):1376-1385
17. Schmid C, Schleuning M, Ledderose G et al (2005) Sequential regimen of chemotherapy, reduced-intensity conditioning for allogeneic stem-cell transplantation, and prophylactic donor lymphocyte transfusion in high-risk acute myeloid leukemia and myelodysplastic syndrome. J Clin Oncol 23(24):5675-5687
18. Schmid C, Schleuning M, Schwerdtfeger R et al (2006) Long-term survival in refractory acute myeloid leukemia after sequential treatment with chemotherapy and reduced-intensity conditioning for allogeneic stem cell transplantation. Blood 108(3):1092-1099
19. Zohren F, Czibere A, Bruns I et al (2009) Fludarabine, amsacrine, high-dose cytarabine and 12 Gy total body irradiation followed by allogeneic hematopoietic stem cell transplantation is effective in patients with relapsed or high-risk acute lymphoblastic leukemia. Bone Marrow Transplant 44(12):785-792
20. Bene MC, Castoldi G, Knapp W et al (1995) Proposals for the immunological classification of acute leukemias. European Group for the Immunological Characterization of Leukemias (EGIL). Leukemia 9(10):1783-1786
21. Xuan L, Huang F, Fan Z et al (2012) Effects of intensified conditioning on Epstein-Barr virus and cytomegalovirus infections in allogeneic hematopoietic stem cell transplantation for hematological malignancies. J Hematol Oncol 5:46
22. Mrozek K, Heerema NA, Bloomfield CD (2004) Cytogenetics in acute leukemia. Blood Rev 18(2):115-136
23. Bearman SI, Appelbaum FR, Buckner CD et al (1988) Regimen-related toxicity in patients undergoing bone marrow transplantation. J Clin Oncol 6(10):1562-1568
24. Strober S (2008) Protective conditioning against GVHD and graft rejection after combined organ and hematopoietic cell transplantation. Blood Cells Mol Dis 40(1):48-54
25. de Lima M, Anagnostopoulos A, Munsell M et al (2004) Nonablative versus reduced-intensity conditioning regimens in the treatment of acute myeloid leukemia and high-risk myelodysplastic syndrome: dose is relevant for long-term disease control after allogeneic hematopoietic stem cell transplantation. Blood 104(3):865-872
26. Mineishi S, Longo WL, Atkinson ME et al (1999) Addition of high-dose Ara-C to the BMT conditioning regimen reduces leukemia relapse without an increase in toxicity. Bone Marrow Transplant 23(12):1217-1222
27. Giebel S, Labopin M, Holowiecki J et al (2009) Outcome of HLA-matched related allogeneic hematopoietic stem cell transplantation for patients with acute leukemia in first complete remission treated in Eastern European centers. Better results in recent years. Ann Hematol 88(10):1005-1013
28. Hamadani M, Awan FT, Copelan EA (2008) Hematopoietic stem cell transplantation in adults with acute myeloid leukemia. Biol Blood Marrow Transplant 14(5):556-567
29. Hough R, Rocha V (2010) Transplant outcomes in acute leukemia. II. Semin Hematol 47(1):51-58
30. Pulte D, Gondos A, Brenner H (2009) Improvement in survival in younger patients with acute lymphoblastic leukemia from the 1980s to the early 21st century. Blood 113(7):1408-1411
31. Vogelsang GB, Hess AD, Santos GW (1988) Acute graft-versus-host disease: clinical characteristics in the cyclosporine era. Medicine 67(3):163-174
32. Mehta J, Powles R, Horton C et al (1994) Bone marrow transplantation for primary refractory acute leukaemia. Bone Marrow Transplant 14(3):415-418
33. Petersen FB, Appelbaum FR, Buckner CD et al (1988) Simultaneous infusion of high-dose cytosine arabinoside with cyclophosphamide followed by total body irradiation and marrow infusion for the treatment of patients with advanced hematological malignancy. Bone Marrow Transplant 3(6):619-624
34. Ringden O, Labopin M, Bacigalupo A et al (2002) Transplantation of peripheral blood stem cells as compared with bone marrow from HLA-identical siblings in adult patients with acute myeloid leukemia and acute lymphoblastic leukemia. J Clin Oncol 20(24):4655-4664